![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ANDRX ANNOUNCES FILING OF NDA BY TAKEDA FOR ACTOS
ANDRX ANNOUNCES FILING OF NDA BY TAKEDA FOR ACTOS
April 4, 2006
Andrx Corporation announced today that Takeda Global Research & Development Center Inc. filed a New Drug Application (NDA) for a combination product consisting of Takeda's ACTOS (pioglitazone HCl) and Andrx's extended-release metformin to the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=100849)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct